Publication | Closed Access
Comparing cardiovascular benefits between GLP-1 receptor agonists and SGLT2 inhibitors as an add-on to metformin among patients with type 2 diabetes: A retrospective cohort study
21
Citations
17
References
2021
Year
Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseDiabetesPharmacologyType 2Diabetes MellitusMedicineCardiovascular BenefitsSglt2 Inhibitors
| Year | Citations | |
|---|---|---|
Page 1
Page 1